# VIMIZIM

NDC: 68135-100
Generic name: elosulfase alfa
Labeler / Manufacturer: BioMarin Pharmaceutical Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20140214

FDA application: BLA125460

## Active ingredients

- ELOSULFASE ALFA: 5 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68135-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68135-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0caa2565-12b2-0ad0-1f9a-273e81c3d4cc